Cava, Optoro and a bunch of biotechs: The top 10 venture deals of 2018

It is likely that 2018 is the best year for venture capital in recent memory. Some of the most well-known startups in Greater Washington got fresh infusions of venture capital in 2018, propelling growth and fueling acquisitions. Meanwhile some new players broke into the top ranks of VC deals, including recent spinoff Viela Bio. The top 10 deals of the year are a reminder t hat 2018 has been particularly good for larger startups. The region saw $1.42 billion in venture funding through the first three…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news